Avelos Therapeutics
Latest round
- Series B
Last raised
- Apr 2024
Total raised
- $20M
Investors
- 13
About Avelos Therapeutics
Founded in 2021, and based in Seoul, South Korea, Avelos Therapeutics Inc. operates as a research company that develops various technologies. In July 2022, Avelos Therapeutics Inc. The company offers various targeted oncology medicine applications that include cell cycle regulation, undruggable cancer targets, and DNA damage for synthetic lethality. In addition, two projects aim to advance to the clinical stage by 2025.
Who invested in Avelos Therapeutics
13 investors across 2 rounds
See all investors in Avelos Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Avelos Therapeutics
Who invested in Avelos Therapeutics?
Avelos Therapeutics has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avelos Therapeutics raised?
Avelos Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Avelos Therapeutics last raise money?
Avelos Therapeutics's most recent round on record is a Series B, in Apr 2024.
What does Avelos Therapeutics do?
Founded in 2021, and based in Seoul, South Korea, Avelos Therapeutics Inc.
Where is Avelos Therapeutics headquartered?
Avelos Therapeutics is headquartered in Seoul, South Korea.
Which VCs invest in companies like Avelos Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Avelos Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Avelos Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.